Pay in 4 interest-free payments of $6.32 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
We do this to show different motifs for different user groups
Dry eye disease: an immune-mediated ocular surface disorder
Lixisenatide, a GLP-1R agonist, reduces neurofibrillary tangles and amyloid plaque load, and thereby ameliorates learning memory deficits in APP/PS1 mice (144, 157)
Altogether, this supports the idea that bacterial inactivation by PTLs arises not from a single factor, but from multi-target, synergistic interactions among oxidative agents and environmental acidity
Discovery, development, and clinical proof of mechanism of LY3463251, a long-acting GDF15 receptor agonist
US$ 20.16
US$ 20.91
US$ 29.12
US$ 27.48
